NCT05162027: A trial that was reported late by University of Maryland, Baltimore
This trial has reported, although it was 13 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT05162027 |
|---|---|
| Title | Erenumab as a Therapeutic Approach for the Management of Painful Chronic Temporomandibular Disorders (TMD) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 1, 2022 |
| Completion date | Jan. 3, 2023 |
| Required reporting date | Jan. 3, 2024, midnight |
| Actual reporting date | Jan. 16, 2024 |
| Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
| Days late | 13 |